Genetic or Therapeutic Neutralization of ALK1 Reduces LDL Transcytosis and Atherosclerosis in Mice

Investigators showed that genetic deletion of activin-like kinase receptor (ALK1) in arterial endothelial cells of mice substantially limited low-density lipoprotein accumulation, macrophage infiltration and atherosclerosis without affecting cholesterol or triglyceride levels.